nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—Leukopenia—Dactinomycin—germ cell cancer	0.00199	0.00199	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Cisplatin—germ cell cancer	0.00198	0.00198	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Cisplatin—germ cell cancer	0.00198	0.00198	CcSEcCtD
Gadobenate Dimeglumine—Pain—Vinblastine—germ cell cancer	0.00197	0.00197	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Vinblastine—germ cell cancer	0.00197	0.00197	CcSEcCtD
Gadobenate Dimeglumine—Pulmonary oedema—Methotrexate—germ cell cancer	0.00196	0.00196	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Bleomycin—germ cell cancer	0.00196	0.00196	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Bleomycin—germ cell cancer	0.00195	0.00195	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Cisplatin—germ cell cancer	0.00195	0.00195	CcSEcCtD
Gadobenate Dimeglumine—Infection—Bleomycin—germ cell cancer	0.00193	0.00193	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Vinblastine—germ cell cancer	0.0019	0.0019	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Dactinomycin—germ cell cancer	0.00189	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00189	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Cisplatin—germ cell cancer	0.00189	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00189	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Ifosfamide—germ cell cancer	0.00189	0.00189	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Cisplatin—germ cell cancer	0.00188	0.00188	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Cisplatin—germ cell cancer	0.00187	0.00187	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Cisplatin—germ cell cancer	0.00187	0.00187	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Dactinomycin—germ cell cancer	0.00187	0.00187	CcSEcCtD
Gadobenate Dimeglumine—Angioedema—Ifosfamide—germ cell cancer	0.00186	0.00186	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Etoposide—germ cell cancer	0.00184	0.00184	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Ifosfamide—germ cell cancer	0.00184	0.00184	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Etoposide—germ cell cancer	0.00183	0.00183	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Ifosfamide—germ cell cancer	0.00183	0.00183	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Cisplatin—germ cell cancer	0.00182	0.00182	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Vinblastine—germ cell cancer	0.00182	0.00182	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Cisplatin—germ cell cancer	0.00182	0.00182	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Bleomycin—germ cell cancer	0.00182	0.00182	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Etoposide—germ cell cancer	0.00181	0.00181	CcSEcCtD
Gadobenate Dimeglumine—Infection—Dactinomycin—germ cell cancer	0.0018	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Cisplatin—germ cell cancer	0.0018	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Ifosfamide—germ cell cancer	0.0018	0.0018	CcSEcCtD
Gadobenate Dimeglumine—Cough—Ifosfamide—germ cell cancer	0.00178	0.00178	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00177	0.00177	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Ifosfamide—germ cell cancer	0.00176	0.00176	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Cisplatin—germ cell cancer	0.00176	0.00176	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Cisplatin—germ cell cancer	0.00176	0.00176	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Bleomycin—germ cell cancer	0.00175	0.00175	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Bleomycin—germ cell cancer	0.00174	0.00174	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Ifosfamide—germ cell cancer	0.00174	0.00174	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Ifosfamide—germ cell cancer	0.00174	0.00174	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Ifosfamide—germ cell cancer	0.00174	0.00174	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Etoposide—germ cell cancer	0.00173	0.00173	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00172	0.00172	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Etoposide—germ cell cancer	0.00172	0.00172	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Etoposide—germ cell cancer	0.00172	0.00172	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Ifosfamide—germ cell cancer	0.00172	0.00172	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Vinblastine—germ cell cancer	0.0017	0.0017	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Cisplatin—germ cell cancer	0.00169	0.00169	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Etoposide—germ cell cancer	0.00168	0.00168	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Ifosfamide—germ cell cancer	0.00168	0.00168	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Etoposide—germ cell cancer	0.00167	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Etoposide—germ cell cancer	0.00167	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Pain—Bleomycin—germ cell cancer	0.00167	0.00167	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00166	0.00166	CcSEcCtD
Gadobenate Dimeglumine—Chills—Etoposide—germ cell cancer	0.00166	0.00166	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.00166	0.00166	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00165	0.00165	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Vinblastine—germ cell cancer	0.00165	0.00165	CcSEcCtD
Gadobenate Dimeglumine—Infection—Ifosfamide—germ cell cancer	0.00165	0.00165	CcSEcCtD
Gadobenate Dimeglumine—Tremor—Cisplatin—germ cell cancer	0.00165	0.00165	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Ifosfamide—germ cell cancer	0.00163	0.00163	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Cisplatin—germ cell cancer	0.00163	0.00163	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Cisplatin—germ cell cancer	0.00163	0.00163	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Ifosfamide—germ cell cancer	0.00162	0.00162	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00161	0.00161	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Bleomycin—germ cell cancer	0.0016	0.0016	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Cisplatin—germ cell cancer	0.00159	0.00159	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Vinblastine—germ cell cancer	0.00158	0.00158	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Etoposide—germ cell cancer	0.00158	0.00158	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Cisplatin—germ cell cancer	0.00157	0.00157	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Dactinomycin—germ cell cancer	0.00157	0.00157	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Etoposide—germ cell cancer	0.00156	0.00156	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Ifosfamide—germ cell cancer	0.00156	0.00156	CcSEcCtD
Gadobenate Dimeglumine—Pain—Dactinomycin—germ cell cancer	0.00155	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Etoposide—germ cell cancer	0.00155	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Bleomycin—germ cell cancer	0.00155	0.00155	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Bleomycin—germ cell cancer	0.00154	0.00154	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Vinblastine—germ cell cancer	0.00152	0.00152	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00152	0.00152	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Cisplatin—germ cell cancer	0.0015	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Dactinomycin—germ cell cancer	0.0015	0.0015	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Ifosfamide—germ cell cancer	0.00149	0.00149	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Etoposide—germ cell cancer	0.00149	0.00149	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Cisplatin—germ cell cancer	0.00149	0.00149	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Etoposide—germ cell cancer	0.00149	0.00149	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00149	0.00149	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00149	0.00149	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Ifosfamide—germ cell cancer	0.00148	0.00148	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Ifosfamide—germ cell cancer	0.00148	0.00148	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Methotrexate—germ cell cancer	0.00148	0.00148	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Cisplatin—germ cell cancer	0.00148	0.00148	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Vinblastine—germ cell cancer	0.00147	0.00147	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Etoposide—germ cell cancer	0.00145	0.00145	CcSEcCtD
Gadobenate Dimeglumine—Headache—Vinblastine—germ cell cancer	0.00144	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Etoposide—germ cell cancer	0.00144	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00144	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Dactinomycin—germ cell cancer	0.00144	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Dactinomycin—germ cell cancer	0.00144	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Ifosfamide—germ cell cancer	0.00144	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Cisplatin—germ cell cancer	0.00144	0.00144	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Bleomycin—germ cell cancer	0.00143	0.00143	CcSEcCtD
Gadobenate Dimeglumine—Infection—Cisplatin—germ cell cancer	0.00143	0.00143	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Ifosfamide—germ cell cancer	0.00142	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Pain—Ifosfamide—germ cell cancer	0.00142	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Etoposide—germ cell cancer	0.00142	0.00142	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Cisplatin—germ cell cancer	0.00141	0.00141	CcSEcCtD
Gadobenate Dimeglumine—Cough—Etoposide—germ cell cancer	0.00141	0.00141	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Cisplatin—germ cell cancer	0.0014	0.0014	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Bleomycin—germ cell cancer	0.0014	0.0014	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Cisplatin—germ cell cancer	0.00139	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Etoposide—germ cell cancer	0.00139	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Cisplatin—germ cell cancer	0.00139	0.00139	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Methotrexate—germ cell cancer	0.00138	0.00138	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Bleomycin—germ cell cancer	0.00138	0.00138	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Ifosfamide—germ cell cancer	0.00137	0.00137	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Etoposide—germ cell cancer	0.00137	0.00137	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Vinblastine—germ cell cancer	0.00137	0.00137	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00136	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00136	0.00136	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Etoposide—germ cell cancer	0.00135	0.00135	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Cisplatin—germ cell cancer	0.00134	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Dactinomycin—germ cell cancer	0.00134	0.00134	CcSEcCtD
Gadobenate Dimeglumine—Abdominal discomfort—Methotrexate—germ cell cancer	0.00133	0.00133	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Etoposide—germ cell cancer	0.00133	0.00133	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Ifosfamide—germ cell cancer	0.00132	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Ifosfamide—germ cell cancer	0.00132	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Ifosfamide—germ cell cancer	0.00132	0.00132	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Etoposide—germ cell cancer	0.00131	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00131	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Infection—Etoposide—germ cell cancer	0.00131	0.00131	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Dactinomycin—germ cell cancer	0.0013	0.0013	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Cisplatin—germ cell cancer	0.00129	0.00129	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Etoposide—germ cell cancer	0.00128	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Cisplatin—germ cell cancer	0.00128	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Etoposide—germ cell cancer	0.00128	0.00128	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Etoposide—germ cell cancer	0.00127	0.00127	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Dactinomycin—germ cell cancer	0.00124	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00124	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Bleomycin—germ cell cancer	0.00124	0.00124	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Methotrexate—germ cell cancer	0.00123	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Methotrexate—germ cell cancer	0.00123	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Etoposide—germ cell cancer	0.00123	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Rash—Bleomycin—germ cell cancer	0.00123	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Pain—Cisplatin—germ cell cancer	0.00123	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Bleomycin—germ cell cancer	0.00123	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Ifosfamide—germ cell cancer	0.00123	0.00123	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Methotrexate—germ cell cancer	0.00121	0.00121	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Methotrexate—germ cell cancer	0.0012	0.0012	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Ifosfamide—germ cell cancer	0.00119	0.00119	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Methotrexate—germ cell cancer	0.00118	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Cisplatin—germ cell cancer	0.00118	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Etoposide—germ cell cancer	0.00118	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Ifosfamide—germ cell cancer	0.00118	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Methotrexate—germ cell cancer	0.00118	0.00118	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Etoposide—germ cell cancer	0.00117	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Etoposide—germ cell cancer	0.00117	0.00117	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Bleomycin—germ cell cancer	0.00116	0.00116	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Dactinomycin—germ cell cancer	0.00115	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Rash—Dactinomycin—germ cell cancer	0.00115	0.00115	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Ifosfamide—germ cell cancer	0.00114	0.00114	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00113	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Cisplatin—germ cell cancer	0.00113	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Etoposide—germ cell cancer	0.00113	0.00113	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Etoposide—germ cell cancer	0.00112	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Pain—Etoposide—germ cell cancer	0.00112	0.00112	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Ifosfamide—germ cell cancer	0.0011	0.0011	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Methotrexate—germ cell cancer	0.00109	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Methotrexate—germ cell cancer	0.00109	0.00109	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Etoposide—germ cell cancer	0.00108	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Dactinomycin—germ cell cancer	0.00108	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Etoposide—germ cell cancer	0.00108	0.00108	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Methotrexate—germ cell cancer	0.00107	0.00107	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Ifosfamide—germ cell cancer	0.00106	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Cisplatin—germ cell cancer	0.00106	0.00106	CcSEcCtD
Gadobenate Dimeglumine—Rash—Ifosfamide—germ cell cancer	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Ifosfamide—germ cell cancer	0.00105	0.00105	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Etoposide—germ cell cancer	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Etoposide—germ cell cancer	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Etoposide—germ cell cancer	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Methotrexate—germ cell cancer	0.00104	0.00104	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Methotrexate—germ cell cancer	0.00103	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Cisplatin—germ cell cancer	0.00103	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Methotrexate—germ cell cancer	0.00103	0.00103	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Methotrexate—germ cell cancer	0.00101	0.00101	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Methotrexate—germ cell cancer	0.001	0.001	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Methotrexate—germ cell cancer	0.000999	0.000999	CcSEcCtD
Gadobenate Dimeglumine—Chills—Methotrexate—germ cell cancer	0.000995	0.000995	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Ifosfamide—germ cell cancer	0.000989	0.000989	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Cisplatin—germ cell cancer	0.000982	0.000982	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Methotrexate—germ cell cancer	0.000971	0.000971	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Etoposide—germ cell cancer	0.000969	0.000969	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Methotrexate—germ cell cancer	0.000965	0.000965	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Methotrexate—germ cell cancer	0.000965	0.000965	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Methotrexate—germ cell cancer	0.000945	0.000945	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Etoposide—germ cell cancer	0.000943	0.000943	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Methotrexate—germ cell cancer	0.000933	0.000933	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Etoposide—germ cell cancer	0.00093	0.00093	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Cisplatin—germ cell cancer	0.000912	0.000912	CcSEcCtD
Gadobenate Dimeglumine—Rash—Cisplatin—germ cell cancer	0.000905	0.000905	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Cisplatin—germ cell cancer	0.000904	0.000904	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Etoposide—germ cell cancer	0.000899	0.000899	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000895	0.000895	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Methotrexate—germ cell cancer	0.000892	0.000892	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Methotrexate—germ cell cancer	0.00087	0.00087	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Etoposide—germ cell cancer	0.000869	0.000869	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Methotrexate—germ cell cancer	0.000864	0.000864	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Cisplatin—germ cell cancer	0.000852	0.000852	CcSEcCtD
Gadobenate Dimeglumine—Cough—Methotrexate—germ cell cancer	0.000842	0.000842	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Etoposide—germ cell cancer	0.000836	0.000836	CcSEcCtD
Gadobenate Dimeglumine—Rash—Etoposide—germ cell cancer	0.000829	0.000829	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Etoposide—germ cell cancer	0.000828	0.000828	CcSEcCtD
Gadobenate Dimeglumine—Headache—Etoposide—germ cell cancer	0.000824	0.000824	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methotrexate—germ cell cancer	0.000821	0.000821	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Methotrexate—germ cell cancer	0.000821	0.000821	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methotrexate—germ cell cancer	0.000821	0.000821	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000816	0.000816	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methotrexate—germ cell cancer	0.000812	0.000812	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Methotrexate—germ cell cancer	0.000794	0.000794	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methotrexate—germ cell cancer	0.000787	0.000787	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methotrexate—germ cell cancer	0.000782	0.000782	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Etoposide—germ cell cancer	0.000781	0.000781	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methotrexate—germ cell cancer	0.000772	0.000772	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methotrexate—germ cell cancer	0.000765	0.000765	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methotrexate—germ cell cancer	0.000761	0.000761	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methotrexate—germ cell cancer	0.000736	0.000736	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000717	0.000717	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methotrexate—germ cell cancer	0.000707	0.000707	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Methotrexate—germ cell cancer	0.000702	0.000702	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Methotrexate—germ cell cancer	0.0007	0.0007	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methotrexate—germ cell cancer	0.000693	0.000693	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00068	0.00068	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methotrexate—germ cell cancer	0.000679	0.000679	CcSEcCtD
Gadobenate Dimeglumine—Pain—Methotrexate—germ cell cancer	0.000673	0.000673	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Methotrexate—germ cell cancer	0.000649	0.000649	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000644	0.000644	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methotrexate—germ cell cancer	0.000626	0.000626	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methotrexate—germ cell cancer	0.000622	0.000622	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Methotrexate—germ cell cancer	0.000622	0.000622	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methotrexate—germ cell cancer	0.00058	0.00058	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Methotrexate—germ cell cancer	0.000565	0.000565	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Methotrexate—germ cell cancer	0.000557	0.000557	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methotrexate—germ cell cancer	0.000539	0.000539	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Methotrexate—germ cell cancer	0.000521	0.000521	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methotrexate—germ cell cancer	0.000501	0.000501	CcSEcCtD
Gadobenate Dimeglumine—Rash—Methotrexate—germ cell cancer	0.000497	0.000497	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methotrexate—germ cell cancer	0.000496	0.000496	CcSEcCtD
Gadobenate Dimeglumine—Headache—Methotrexate—germ cell cancer	0.000493	0.000493	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methotrexate—germ cell cancer	0.000468	0.000468	CcSEcCtD
